{
  "docId": "019de076-c164-739c-925e-e97b24983f20",
  "docSlug": "45699c5d62cd10656fd74cee2718d284",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 45,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a horizontal list/matrix structure to categorize technology platforms by therapeutic area and partner/internal status.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-c164-739c-925e-e97b24983f20/9",
  "deckHref": "/decks/019de076-c164-739c-925e-e97b24983f20",
  "deckJsonHref": "/decks/019de076-c164-739c-925e-e97b24983f20.json",
  "deckAnchorHref": "/decks/019de076-c164-739c-925e-e97b24983f20#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.78,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "Gracell Biotechnologies, Inc. acquisition remains subject to customary closing conditions; all clinical development plans mentioned herein subject to deal closure. AstraZeneca acquired TeneoTwo, part of Ancora Biotech.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d5f2924-7992-400f-b745-56daba018632",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.68,
        "w": 0.94,
        "x": 0.03,
        "y": 0.208
      },
      "kind": "framework",
      "text": "Technology Platform Matrix",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54913f57-140c-4100-af67-114161791da4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.52,
        "x": 0.28,
        "y": 0.28
      },
      "kind": "image",
      "text": "Daiichi-Sankyo, neogene, Quell, cellectis, GRACELL, Ancora Biotech, HARBOUR BIOMED, Pfizer",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "173f6838-64f0-4b93-a6af-be7c80795f7e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.15,
        "x": 0.07,
        "y": 0.28
      },
      "kind": "list",
      "text": "NOVEL ADCS, CELL THERAPY, T-CELL ENGAGERS, GENE THERAPY",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a86dc637-1e2d-498d-8937-dedb94e58730",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.35,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Shaping the future of medicine",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7a7a7dc-cf70-464e-9383-a130ffded6ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.73,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "Investing in new platforms and technologies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a521224-c223-4609-a153-671e31e2a3ba",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "627f80a5-7535-4ad2-839f-42eaa339ef10",
      "evidence": "Technology Platform Matrix",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "matrix-nxn",
      "slug": null,
      "matchId": "1bd79b53-ac35-492f-92bc-7a2ff8c329ac",
      "evidence": "Categorization of platforms by type, internal/partner status, and therapeutic area.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "d160a662-8b01-43c0-9e51-53722043f0ea",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document highlights AstraZeneca's growth ambition and the need for innovation",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 5,
      "name": "Aha Moment",
      "slug": "03-aha-moment",
      "bestFor": "Data-heavy sections, research findings, analytical arguments",
      "matchId": "2e86e557-88b9-48e3-adcc-fb5baf8c3183",
      "evidence": "The document highlights AstraZeneca's growth ambition and pipeline success",
      "position": 0,
      "objective": "What are AstraZeneca's key growth drivers?",
      "structure": "The Problem/Question -> What the Data Shows -> The Insight",
      "confidence": 0.6,
      "description": "Establish a tension, present data, then deliver the insight that changes everything"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}